Physician
Friendly Urgent Care, LLC
Friendly Urgent Care, LLC was paid $8.65M by Medicaid between Jan 2018 and Sep 2024, across 46 billing codes. Its largest line is S9083, Global fee urgent care centers — 33% of everything it billed.
33Billing provider infoFRIENDLY URGENT CARE, LLC
TEANECK, NJ 07666
TEANECK, NJ 07666
33aNPI1255843876assigned 11/05/2017
33bProvider typeGeneral Practice Physician
28Total paid$8.65M
24GClaims190,455
24DCodes billed46
24AFirst – last monthJan 2018 – Sep 2024
Compared with peers
Next to other General Practice Physician providers in New Jersey
Rank by total paid#1 of 35
Median peer was paid$17K
This provider vs. median515×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 409 | $39K | |
| 2019 | 14,150 | $845K | |
| 2020 | 31,725 | $1.94M | |
| 2021 | 52,941 | $3.02M | |
| 2022 | 58,410 | $2.16M | |
| 2023 | 32,480 | $634K | |
| 2024incomplete | 340 | $10K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| S9083 | Global fee urgent care centers | 33% | 33,391 | 29,646 | $2.84M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 28,803 | 24,769 | $1.31M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 9.7% | 13,548 | 12,824 | $842K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.0% | 13,512 | 12,106 | $780K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 7.7% | 11,678 | 11,419 | $666K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 6.2% | 18,062 | 15,711 | $537K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.3% | 5,631 | 5,405 | $457K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5.2% | 9,851 | 8,113 | $453K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2.7% | 5,380 | 4,699 | $233K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.1% | 23,065 | 20,713 | $184K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.2% | 2,418 | 2,278 | $105K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 6,698 | 3,477 | $52K |
34 more codes
| M0240 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat doses | <1% | 263 | $50K |
| 86328 | <1% | 877 | $35K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 785 | $22K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 705 | $19K |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | <1% | 63 | $11K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 768 | $10K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 418 | $8K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,752 | $7K |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | <1% | 37 | $5K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 304 | $4K |
| 90686 | <1% | 192 | $4K | |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | <1% | 19 | $4K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 212 | $2K |
| 87081 | <1% | 236 | $2K | |
| 99201 | <1% | 61 | $1K | |
| 87428 | <1% | 80 | $808.39 | |
| 0031A | <1% | 17 | $640.00 | |
| 0011A | <1% | 17 | $560.00 | |
| 73630 | <1% | 27 | $358.32 | |
| 81002 | <1% | 339 | $284.34 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 13 | $202.73 |
| 73110 | <1% | 12 | $188.38 | |
| 73130 | <1% | 13 | $110.54 | |
| 99000 | <1% | 216 | $78.00 | |
| 96127 | <1% | 16 | $38.56 | |
| 99051 | <1% | 195 | $28.00 | |
| 81003 | <1% | 167 | $11.20 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 17 | $0.01 |
| 3008F | 0% | 6,174 | $0.00 | |
| 3074F | 0% | 1,604 | $0.00 | |
| 3075F | 0% | 116 | $0.00 | |
| 3079F | 0% | 534 | $0.00 | |
| 3080F | 0% | 39 | $0.00 | |
| 1160F | 0% | 130 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWERZBERGER, SAMUEL (OWNER)
| Provider | Location | Paid |
|---|---|---|
| BP Immediate Medical Care, PC | Brooklyn, NY | $45.09M |
| Urgent Care Medical Associates Professional Corporation | Dover, NJ | $5K |
| New Health Medical New York PC | Brooklyn, NY | $302.27 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.